1. Home
  2. RMD vs DHI Comparison

RMD vs DHI Comparison

Compare RMD & DHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RMD
  • DHI
  • Stock Information
  • Founded
  • RMD 1989
  • DHI 1978
  • Country
  • RMD United States
  • DHI United States
  • Employees
  • RMD N/A
  • DHI N/A
  • Industry
  • RMD Medical/Dental Instruments
  • DHI Homebuilding
  • Sector
  • RMD Health Care
  • DHI Consumer Discretionary
  • Exchange
  • RMD Nasdaq
  • DHI Nasdaq
  • Market Cap
  • RMD 40.7B
  • DHI 45.9B
  • IPO Year
  • RMD 1995
  • DHI 1992
  • Fundamental
  • Price
  • RMD $283.93
  • DHI $156.37
  • Analyst Decision
  • RMD Buy
  • DHI Buy
  • Analyst Count
  • RMD 13
  • DHI 15
  • Target Price
  • RMD $276.82
  • DHI $164.50
  • AVG Volume (30 Days)
  • RMD 1.2M
  • DHI 4.7M
  • Earning Date
  • RMD 07-31-2025
  • DHI 07-22-2025
  • Dividend Yield
  • RMD 0.85%
  • DHI 1.04%
  • EPS Growth
  • RMD 37.43
  • DHI N/A
  • EPS
  • RMD 9.51
  • DHI 12.48
  • Revenue
  • RMD $5,146,327,000.00
  • DHI $34,575,200,000.00
  • Revenue This Year
  • RMD $8.76
  • DHI N/A
  • Revenue Next Year
  • RMD $7.16
  • DHI $1.43
  • P/E Ratio
  • RMD $29.85
  • DHI $12.54
  • Revenue Growth
  • RMD 9.84
  • DHI N/A
  • 52 Week Low
  • RMD $199.92
  • DHI $110.44
  • 52 Week High
  • RMD $293.08
  • DHI $199.85
  • Technical
  • Relative Strength Index (RSI)
  • RMD 65.07
  • DHI 68.44
  • Support Level
  • RMD $277.54
  • DHI $153.58
  • Resistance Level
  • RMD $293.08
  • DHI $158.22
  • Average True Range (ATR)
  • RMD 6.83
  • DHI 4.44
  • MACD
  • RMD 0.60
  • DHI 0.75
  • Stochastic Oscillator
  • RMD 71.42
  • DHI 89.26

About RMD ResMed Inc.

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.

About DHI D.R. Horton Inc.

With operations in 126 markets across 36 states D.R. Horton is the leading homebuilder in the United States. D.R. Horton mainly builds single-family detached homes (87% of home sales revenue) and offers products to entry-level, move-up, luxury buyers, and active adults. The company offers homebuyers mortgage financing and title agency services through its financial services segment. D.R. Horton's headquarters are in Arlington, Texas, and it manages six regional segments across the United States.

Share on Social Networks: